SynaptixBio

Pioneering rare disease biotech

SynaptixBio is a rare disease biotech company that is pioneering ground-breaking treatments for severe leukodystrophies and other childhood neurodegenerative diseases. Their approach aims to create life-saving treatments for severe genetic diseases that affect the central nervous system.

Rather than feature the scientific R&D imagery that is more typical in this sector, we chose to create a striking abstract texture to represent the intricacies of the human brain, giving the brand a highly distinctive visual identity, to help it stand out from its competitors.

Branding | Website